Cytokinetics, Incorporated (CYTK) Operating margin 2016–2025
Cytokinetics, Incorporated (CYTK) operating margin by fiscal year — reported operating income divided by reported revenue.
-695.4%FY2025 · since FY2016: 17.6% → -695.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -695.4% | +2207.3 pp |
| FY2024 | -2902.7% | +3687.0 pp |
| FY2023 | -6589.7% | -6247.0 pp |
| FY2022 | -342.8% | -78.2 pp |
| FY2021 | -264.5% | -96.3 pp |
| FY2020 | -168.3% | +199.7 pp |
| FY2019 | -368.0% | -85.7 pp |
| FY2018 | -282.3% | +566.0 pp |
| FY2017 | -848.3% | -865.8 pp |
| FY2016 | 17.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice